VX-661 Plus Ivacaftor Combination ( DrugBank: Ivacaftor )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	2

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02516410 (ClinicalTrials.gov)	August 2015	28/7/2015	A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effica ...	Cystic Fibrosis	Drug: VX-661 plus ivacaftor combination;Drug: Ivacaftor;Drug: Placebo (matched to VX-661 plus ivacaf ...	Vertex Pharmaceuticals Incorporated	NULL	Completed	12 Years	N/A	All	168	Phase 3	United States;Australia;Austria;Canada;France;Israel;Spain
2	NCT02347657 (ClinicalTrials.gov)	January 2015	12/1/2015	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Sa ...	A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Effica ...	Cystic Fibrosis	Drug: VX-661 Plus Ivacaftor Combination;Drug: Ivacaftor;Drug: VX-661 Plus Ivacaftor CombinationPlace ...	Vertex Pharmaceuticals Incorporated	NULL	Completed	12 Years	N/A	All	510	Phase 3	United States;Canada;Denmark;France;Germany;Ireland;Italy;Netherlands;Spain;Sweden;Switzerland;Unite ...

First Previous1Next Last